| Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia SL Maude, TW Laetsch, J Buechner, S Rives, M Boyer, H Bittencourt, ... New England Journal of Medicine 378 (5), 439-448, 2018 | 4780 | 2018 |
| Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and … S Corbacioglu, E Carreras, M Ansari, A Balduzzi, S Cesaro, JH Dalle, ... Bone marrow transplantation 53 (2), 138-145, 2018 | 305 | 2018 |
| Unrelated donor marrow transplantation in children A Balduzzi, T Gooley, C Anasetti, JE Sanders, PJ Martin, EW Petersdorf, ... | 295 | 1995 |
| Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an … A Balduzzi, MG Valsecchi, C Uderzo, P De Lorenzo, T Klingebiel, ... The Lancet 366 (9486), 635-642, 2005 | 278 | 2005 |
| Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome M Zecca, A Prete, R Rondelli, E Lanino, A Balduzzi, C Messina, F Fagioli, ... Blood, The Journal of the American Society of Hematology 100 (4), 1192-1200, 2002 | 278 | 2002 |
| Imatinib for refractory chronic graft-versus-host disease with fibrotic features A Olivieri, F Locatelli, M Zecca, A Sanna, M Cimminiello, R Raimondi, ... Blood, The Journal of the American Society of Hematology 114 (3), 709-718, 2009 | 274 | 2009 |
| Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients M Introna, G Lucchini, E Dander, S Galimberti, A Rovelli, A Balduzzi, ... Biology of blood and marrow transplantation 20 (3), 375-381, 2014 | 270 | 2014 |
| Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus–related lymphoproliferative disorder after hematopoietic stem cell transplant in children and … J Styczynski, L Gil, G Tridello, P Ljungman, JP Donnelly, ... Clinical infectious diseases 57 (6), 794-802, 2013 | 251 | 2013 |
| Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population G Lucchini, M Introna, E Dander, A Rovelli, A Balduzzi, S Bonanomi, ... Biology of blood and marrow transplantation 16 (9), 1293-1301, 2010 | 242 | 2010 |
| Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantation C Messina, F Locatelli, E Lanino, C Uderzo, G Zacchello, S Cesaro, ... British journal of haematology 122 (1), 118-127, 2003 | 228 | 2003 |
| Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment O Hrusak, T Kalina, J Wolf, A Balduzzi, M Provenzi, C Rizzari, S Rives, ... European Journal of Cancer 132, 11-16, 2020 | 225 | 2020 |
| Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study C Peters, JH Dalle, F Locatelli, U Poetschger, P Sedlacek, J Buechner, ... Journal of Clinical Oncology 39 (4), 295-307, 2021 | 223 | 2021 |
| Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact … T Klingebiel, J Cornish, M Labopin, F Locatelli, P Darbyshire, ... Blood, The Journal of the American Society of Hematology 115 (17), 3437-3446, 2010 | 206 | 2010 |
| The COVID‐19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global M Sullivan, E Bouffet, C Rodriguez‐Galindo, S Luna‐Fineman, MS Khan, ... Pediatric blood & cancer 67 (7), e28409, 2020 | 180 | 2020 |
| Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+ CD25+ GITR+ Foxp3+ CD62L+ functional regulatory T-cells in patients with graft-versus … E Biagi, I Di Biaso, V Leoni, G Gaipa, V Rossi, C Bugarin, G Renoldi, ... Transplantation 84 (1), 31-39, 2007 | 180 | 2007 |
| Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia … A Balduzzi, E Brivio, A Rovelli, C Rizzari, S Gasperini, ML Melzi, V Conter, ... Bone Marrow Transplantation 55 (10), 1900-1905, 2020 | 174 | 2020 |
| Interleukin-17–producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation E Dander, A Balduzzi, G Zappa, G Lucchini, P Perseghin, V Andre, ... Transplantation 88 (11), 1261-1272, 2009 | 167 | 2009 |
| Three-year update of tisagenlecleucel in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia in the ELIANA trial TW Laetsch, SL Maude, S Rives, H Hiramatsu, H Bittencourt, P Bader, ... Journal of Clinical Oncology 41 (9), 1664-1669, 2023 | 139 | 2023 |
| Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities CF Magnani, G Gaipa, F Lussana, D Belotti, G Gritti, S Napolitano, ... The Journal of clinical investigation 130 (11), 6021-6033, 2020 | 131 | 2020 |
| Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation P Corti, C Uderzo, A Tagliabue, A Della Volpe, C Annaloro, E Tagliaferri, ... Bone marrow transplantation 29 (6), 542-543, 2002 | 124 | 2002 |
